Here are four things to know:
1. MAST investigators are currently focusing on areas of the microbiome linked to irritable bowel syndrome and small intestinal bacterial overgrowth.
2. The Cedars-Sinai Technology Transfer Office and the Burns & Allen Research Institute at Cedars-Sinai partnered to create the program.
3. Since its inception, MAST researchers have developed a breath test to identify the presence of hydrogen sulfide among gases present in patients with diarrhea. The program has applied for patents for a four-gas breath test device, which is expected to be available to patients by the end of 2018.
4. The MAST team also developed Lotus, a system designed to safely and precisely collect samples from patients’ small intestines. Cedars-Sinai licensed the technology to Stafford Springs, Conn.-based Hobbs Medical, an endoscopy accessories manufacturer and supplier.
Here is more information on the MAST program.
More articles on gastroenterology:
GI leader to know: Dr. Mark Bronner of Louisville Gastroenterology Associates
Beating CRC, one test at a time — Exact Sciences’ Mark Stenhouse stumps for Cologuard
5 most read GI/endoscopy stories: June 18-22
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.